The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|91|3|550-554

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.3, 2012-03, pp. : 550-554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

STroke imAging pRevention and treatment (START): A longitudinal stroke cohort study: Clinical trials protocol

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 4, 2015-06 ,pp. : 636-644

John Wiley & Sons Inc

Access to resources Recommend Favorite

The importance of considering ADHD in smoking cessation clinical trials

By Bidwell L Cinnamon   Leventhal Adam M  

Clinical Investigation, Vol. 3, Iss. 6, 2013-06 ,pp. : 511-514

Future Science

Access to resources Recommend Favorite

Missing data in clinical research: an integrated approach

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1463-1465

John Wiley & Sons Inc

Access to resources Recommend Favorite

The importance of communication in secondary fragility fracture treatment and prevention

By Meadows L.   Mrkonjic L.   O’Brien M.   Tink W.  

Osteoporosis International, Vol. 18, Iss. 2, 2007-02 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite

Data Monitoring Committees in adaptive clinical trials

By Lin Min   Chow Shein-Chung  

Clinical Investigation, Vol. 3, Iss. 7, 2013-07 ,pp. : 605-607

Future Science

Access to resources Recommend Favorite